MENU

NTLA Intellia Therapeutics Forecast, Technical & Fundamental Analysis

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTLA is expected to report earnings to -80 cents per share on November 05

Intellia Therapeutics NTLA Stock Earnings Reports
Q3'26
Est.
$-0.80
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 1.31M shares outstanding, the current market capitalization sits at 1.79B.
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ASA63.732.53
+4.13%
ASA Gold AND Precious Metals Limited
VAMO37.060.38
+1.04%
Cambria Value and Momentum ETF
ELIL28.130.09
+0.33%
Direxion Daily LLY Bull 2X Shares
VMSB48.97N/A
N/A
Voya Multi Sector Income ETF
PCLO24.90-0.01
-0.02%
Virtus SEIX AAA Private Credit CLO ETF

NTLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+0.59%
VCYT - NTLA
69%
Closely correlated
+3.34%
CRSP - NTLA
61%
Loosely correlated
+0.18%
BEAM - NTLA
60%
Loosely correlated
+0.93%
PRME - NTLA
58%
Loosely correlated
+2.80%
EDIT - NTLA
56%
Loosely correlated
+0.33%
More
Intellia Therapeutics (NTLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com